Molecular identification of an enzyme reported over 60 years ago

From the 1950s to 1970s, discovery of enzymes began by identifying new chemical reactions within cell-free extracts, but ...
Fierce Biotech

Lynk points to phase 3 eczema win as more proof of next-gen JAK inhibitor's potential

Lynk Pharmaceuticals has reported another phase 3 win in China for its next-gen JAK inhibitor, this time hitting skin clearance goals among patients with eczema. | Lynk Pharmaceuticals has reported ...